{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:56:01Z","timestamp":1791093361188,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.canlet.2013.01.020","type":"journal-article","created":{"date-parts":[[2013,1,21]],"date-time":"2013-01-21T20:08:51Z","timestamp":1358798931000},"page":"76-88","source":"Crossref","is-referenced-by-count":46,"title":["Pharmacological inhibition of carbonic anhydrase XII interferes with cell proliferation and induces cell apoptosis in T-cell lymphomas"],"prefix":"10.1016","volume":"333","author":[{"given":"Nadia","family":"Lounnas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9lia","family":"Rosilio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marielle","family":"Nebout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Mary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Griessinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zouhour","family":"Neffati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Chiche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hergen","family":"Spits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thijs J.","family":"Hagenbeek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahid","family":"Asnafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally-Ann","family":"Poulsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Peyron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Imbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2013.01.020_b0005","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2141.2011.08957.x","article-title":"T-cell acute lymphoblastic leukaemia: recent molecular biology findings","volume":"156","author":"Kraszewska","year":"2012","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.canlet.2013.01.020_b0010","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1182\/blood-2009-07-235143","article-title":"Interconnecting molecular pathways in the pathogenesis and drug sensitivity of T-cell acute lymphoblastic leukemia","volume":"115","author":"Sanda","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2013.01.020_b0015","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11912-012-0227-y","article-title":"PI3K and mTOR signaling pathways in cancer: new data on targeted therapies","volume":"14","author":"Willems","year":"2012","journal-title":"Current Oncology Reports"},{"key":"10.1016\/j.canlet.2013.01.020_b0020","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1172\/JCI34616","article-title":"PTEN posttranslational inactivation and hyperactivation of the PI3K\/Akt pathway sustain primary T cell leukemia viability","volume":"118","author":"Silva","year":"2008","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.canlet.2013.01.020_b0025","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/leu.2009.223","article-title":"Targeted therapy in T-cell malignancies: dysregulation of the cellular signaling pathways","volume":"24","author":"Zhao","year":"2010","journal-title":"Leukemia: Official Journal of the Leukemia Society of America, Leukemia Research Fund, UK"},{"key":"10.1016\/j.canlet.2013.01.020_b0030","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/nm1636","article-title":"Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia","volume":"13","author":"Palomero","year":"2007","journal-title":"Nature Medicine"},{"key":"10.1016\/j.canlet.2013.01.020_b0035","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/leu.2008.178","article-title":"Interleukin-4 stimulates proliferation and growth of T-cell acute lymphoblastic leukemia cells by activating mTOR signaling","volume":"23","author":"Cardoso","year":"2009","journal-title":"Leukemia: Official Journal of the Leukemia Society of America, Leukemia Research Fund, UK"},{"key":"10.1016\/j.canlet.2013.01.020_b0040","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1182\/blood-2009-02-206722","article-title":"High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia","volume":"114","author":"Gutierrez","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2013.01.020_b0045","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/sj.leu.2405056","article-title":"T-cell lymphomas in T-cell-specific Pten-deficient mice originate in the thymus","volume":"22","author":"Hagenbeek","year":"2008","journal-title":"Leukemia: Official Journal of the Leukemia Society of America, Leukemia Research Fund, UK"},{"key":"10.1016\/j.canlet.2013.01.020_b0050","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1084\/jem.20040495","article-title":"The loss of PTEN allows TCR alphabeta lineage thymocytes to bypass IL-7 and Pre-TCR-mediated signaling","volume":"200","author":"Hagenbeek","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.canlet.2013.01.020_b0055","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nature Reviews. Drug Discovery"},{"key":"10.1016\/j.canlet.2013.01.020_b0060","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.3748\/wjg.v9.i7.1398","article-title":"Carbonic anhydrase isozymes IX and XII in gastric tumors","volume":"9","author":"Leppilampi","year":"2003","journal-title":"World Journal of Gastroenterology: WJG"},{"key":"10.1016\/j.canlet.2013.01.020_b0065","doi-asserted-by":"crossref","first-page":"84","DOI":"10.18632\/oncotarget.422","article-title":"Recent developments in targeting carbonic anhydrase IX for cancer therapeutics","volume":"3","author":"McDonald","year":"2012","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2013.01.020_b0070","doi-asserted-by":"crossref","first-page":"7608","DOI":"10.1073\/pnas.95.13.7608","article-title":"Human carbonic anhydrase XII: cDNA cloning, expression, and chromosomal localization of a carbonic anhydrase gene that is overexpressed in some renal cell cancers","volume":"95","author":"Tureci","year":"1998","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.canlet.2013.01.020_b0075","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0002-9440(10)64762-1","article-title":"Expression of a novel transmembrane carbonic anhydrase isozyme XII in normal human gut and colorectal tumors","volume":"156","author":"Kivela","year":"2000","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/j.canlet.2013.01.020_b0080","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0002-9440(10)64048-5","article-title":"Expression of the hypoxia-inducible and tumor-associated carbonic anhydrases in ductal carcinoma in situ of the breast","volume":"158","author":"Wykoff","year":"2001","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/j.canlet.2013.01.020_b0085","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1158\/0008-5472.CAN-08-2470","article-title":"Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH","volume":"69","author":"Chiche","year":"2009","journal-title":"Cancer Research"},{"key":"10.1016\/j.canlet.2013.01.020_b0090","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.ejcb.2010.03.004","article-title":"Carbonic anhydrase XII promotes invasion and migration ability of MDA-MB-231 breast cancer cells through the p38 MAPK signaling pathway","volume":"89","author":"Hsieh","year":"2010","journal-title":"European Journal of Cell Biology"},{"key":"10.1016\/j.canlet.2013.01.020_b0095","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.oraloncology.2011.11.015","article-title":"Tumor-associated carbonic anhydrase XII is linked to the growth of primary oral squamous cell carcinoma and its poor prognosis","volume":"48","author":"Chien","year":"2012","journal-title":"Oral Oncology"},{"key":"10.1016\/j.canlet.2013.01.020_b0100","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1080\/14756360009040695","volume":"15","author":"Supuran","year":"2000","journal-title":"Journal of Enzyme Inhibition"},{"key":"10.1016\/j.canlet.2013.01.020_b0105","first-page":"2240","article-title":"The expression of carbonic anhydrase II in hematological malignancies","volume":"8","author":"Leppilampi","year":"2002","journal-title":"Clinical Cancer Research: an Official Journal of the American Association for Cancer Research"},{"key":"10.1016\/j.canlet.2013.01.020_b0110","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0092-8674(00)80153-1","article-title":"Tyrosine phosphorylation of I kappa B-alpha activates NF-kappa B without proteolytic degradation of I kappa B-alpha","volume":"86","author":"Imbert","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2013.01.020_b0115","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1158\/0008-5472.CAN-10-4261","article-title":"Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors","volume":"71","author":"Lou","year":"2011","journal-title":"Cancer Research"},{"key":"10.1016\/j.canlet.2013.01.020_b0120","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1016\/j.bmcl.2009.02.086","article-title":"Inhibition of carbonic anhydrase isozymes with benzene sulfonamides incorporating thio, sulfinyl and sulfonyl glycoside moieties","volume":"19","author":"Singer","year":"2009","journal-title":"Bioorganic and Medicinal Chemistry Letters"},{"key":"10.1016\/j.canlet.2013.01.020_b0125","doi-asserted-by":"crossref","first-page":"6905","DOI":"10.1021\/jm200892s","article-title":"Targeting hypoxic tumor cell viability with carbohydrate-based carbonic anhydrase IX and XII inhibitors","volume":"54","author":"Morris","year":"2011","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.canlet.2013.01.020_b0130","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1582-4934.2009.00994.x","article-title":"Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer","volume":"14","author":"Chiche","year":"2010","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"10.1016\/j.canlet.2013.01.020_b0135","first-page":"7075","article-title":"Hypoxia-inducible expression of tumor-associated carbonic anhydrases","volume":"60","author":"Wykoff","year":"2000","journal-title":"Cancer Research"},{"key":"10.1016\/j.canlet.2013.01.020_b0140","doi-asserted-by":"crossref","first-page":"e33952","DOI":"10.1371\/journal.pone.0033952","article-title":"CAXII Is a sero-diagnostic marker for lung cancer","volume":"7","author":"Kobayashi","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canlet.2013.01.020_b0145","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.tips.2006.09.002","article-title":"Targeting tumor-associated carbonic anhydrase IX in cancer therapy","volume":"27","author":"Thiry","year":"2006","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.canlet.2013.01.020_b0150","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nrd3554","article-title":"Interfering with pH regulation in tumours as a therapeutic strategy","volume":"10","author":"Neri","year":"2011","journal-title":"Nature Reviews. Drug Discovery"},{"key":"10.1016\/j.canlet.2013.01.020_b0155","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.radonc.2011.05.045","article-title":"Specific inhibition of carbonic anhydrase IX activity enhances the in vivo therapeutic effect of tumor irradiation","volume":"99","author":"Dubois","year":"2011","journal-title":"Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology"},{"key":"10.1016\/j.canlet.2013.01.020_b0160","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/jcp.22400","article-title":"PH control mechanisms of tumor survival and growth","volume":"226","author":"Parks","year":"2011","journal-title":"Journal of Cellular Physiology"},{"key":"10.1016\/j.canlet.2013.01.020_b0165","doi-asserted-by":"crossref","first-page":"6509","DOI":"10.1038\/onc.2010.455","article-title":"New insights into the physiological role of carbonic anhydrase IX in tumour pH regulation","volume":"29","author":"Swietach","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2013.01.020_b0170","doi-asserted-by":"crossref","first-page":"5408","DOI":"10.1158\/0008-5472.CAN-06-4095","article-title":"Proton pump inhibitors induce apoptosis of human B-cell tumors through a caspase-independent mechanism involving reactive oxygen species","volume":"67","author":"De Milito","year":"2007","journal-title":"Cancer Research"},{"key":"10.1016\/j.canlet.2013.01.020_b0175","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/ijc.25009","article-title":"PH-dependent antitumor activity of proton pump inhibitors against human melanoma is mediated by inhibition of tumor acidity","volume":"127","author":"De Milito","year":"2010","journal-title":"International Journal of Cancer. Journal International du Cancer"},{"key":"10.1016\/j.canlet.2013.01.020_b0180","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1085\/jgp.8.6.519","article-title":"The metabolism of tumors in the body","volume":"8","author":"Warburg","year":"1927","journal-title":"The Journal of General Physiology"},{"key":"10.1016\/j.canlet.2013.01.020_b0185","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1113\/jphysiol.2011.220152","article-title":"Lactate flux in astrocytes is enhanced by a non-catalytic action of carbonic anhydrase II","volume":"590","author":"Stridh","year":"2012","journal-title":"The Journal of Physiology"},{"key":"10.1016\/j.canlet.2013.01.020_b0190","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1469-7793.2001.0743h.x","article-title":"Extracellular carbonic anhydrase activity facilitates lactic acid transport in rat skeletal muscle fibres","volume":"531","author":"Wetzel","year":"2001","journal-title":"The Journal of Physiology"},{"key":"10.1016\/j.canlet.2013.01.020_b0195","doi-asserted-by":"crossref","first-page":"47886","DOI":"10.1074\/jbc.M105959200","article-title":"A transport metabolon. Functional interaction of carbonic anhydrase II and chloride\/bicarbonate exchangers","volume":"276","author":"Sterling","year":"2001","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.canlet.2013.01.020_b0200","doi-asserted-by":"crossref","first-page":"C738","DOI":"10.1152\/ajpcell.00157.2007","article-title":"Interactions of transmembrane carbonic anhydrase, CAIX, with bicarbonate transporters","volume":"293","author":"Morgan","year":"2007","journal-title":"American Journal of Physiology. Cell Physiology"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383513000499?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383513000499?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T10:58:04Z","timestamp":1539946684000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383513000499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0304383513000499"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2013.01.020","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}